Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Infectious Diseases

• Publication date

  2014-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/cit748PMID 24253250PMCID PMC3905756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation, Atherosclerosis and Coronary Artery Disease

  2014cited by this paper
• Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.

  2014cited by this paper
• Microbial translocation, immune activation, and HIV disease.

  2013cited by this paper
• Overcoming pharmacologic sanctuaries

  2013cited by this paper
• Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

  2013cited by this paper
• Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

  2013cited by this paper
• Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.

  2012influential reference
• Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.

  2012cited by this paper
• Arterial inflammation in patients with HIV.

  2012cited by this paper
• Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens

  2012cited by this paper
• A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

  2012cited by this paper
• Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

  2012cited by this paper
• The immune system in atherosclerosis

  2011cited by this paper
• Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients

  2011cited by this paper
• Plasma levels of soluble CD14 independently predict mortality in HIV infection.

  2011cited by this paper
• Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

  2011cited by this paper
• High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

  2011cited by this paper
• Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.

  2011cited by this paper
• HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

  2011cited by this paper
• Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

  2010cited by this paper
• Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

  2010cited by this paper
• Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

  2010cited by this paper
• Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

  2010cited by this paper
• Monocytes in atherosclerosis: subsets and functions

  2010cited by this paper
• Human CD 14 dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR 7 and TLR 8 Receptors

  2010cited by this paper
• Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

  2009cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• Failure of atorvastatin to modulate CSF HIV-1 infection

  2008cited by this paper
• HIV infection and high density lipoprotein metabolism.

  2008cited by this paper
• Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

  2007cited by this paper
• The CD14+ CD16+ blood monocytes: their role in infection and inflammation

  2007cited by this paper
• CD16+ monocytes produce IL‐6, CCL2, and matrix metalloproteinase‐9 upon interaction with CX3CL1‐expressing endothelial cells

  2006cited by this paper
• Role of tissue factor in hemostasis and thrombosis.

  2006cited by this paper
• Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy.

  2005cited by this paper
• Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes

  2005cited by this paper
• Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms

  2005cited by this paper
• Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function

  2005cited by this paper
• The Effect of Statins on HIV Rebound and Blips

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Evaluation of the anti-HIV activity of statins

  2005cited by this paper
• Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection

  2004cited by this paper
• Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity

  2004cited by this paper
• Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection

  2004cited by this paper
• Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes

  2003cited by this paper
• A potential role for interleukin-7 in T-cell homeostasis.

  2001cited by this paper
• Accelerated coronary atherosclerosis and arteriosclerosis in young human‐immunodeficiency‐virus‐positive patients

  2000cited by this paper

• The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy

  2025cites this paper
• Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases

  2025cites this paper
• Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial.

  2025cites this paper
• Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial

  2025cites this paper
• Immunity in rodent models of stress.

  2025cites this paper
• Clinical and experimental treatment of residual immune activation in people living with HIV.

  2025cites this paper
• Effect of probiotics supplementation on CD4+ T cell counts and inflammation in adults living with HIV: A systematic review and meta-analysis

  2025cites this paper
• Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

  2024cites this paper
• Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review

  2024cites this paper
• Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection

  2024cites this paper
• Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapy

  2024cites this paper
• Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

  2024cites this paper
• Immune Activation Is Associated With Neurocognitive Performance in Ugandan Adolescents Living With HIV

  2024cites this paper
• Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas

  2024influential citation
• An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV

  2023influential citation
• Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV

  2023cites this paper
• Can statin preventative treatment inform geroscience‐guided therapeutics?

  2023cites this paper
• Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV

  2023cites this paper
• A Systematic Review and Meta-Analysis on the Impact of Statin Treatment in HIV Patients on Antiretroviral Therapy

  2023influential citation
• Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control

  2022cites this paper
• Cardiovascular Disease and Thrombosis in HIV Infection

  2022cites this paper
• Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation

  2022cites this paper
• Old and new damage‐associated molecular patterns (DAMPs) in autoimmune diseases

  2022cites this paper
• HIV and cardiovascular disease: the role of inflammation

  2022cites this paper
• Statins for primary cardiovascular disease prevention among people with HIV: emergent directions

  2022cites this paper
• Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)

  2022cites this paper
• Persistent Inflammation and Non-AIDS Comorbidities During ART: Coming of the Age of Monocytes

  2022cites this paper
• Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy.

  2022cites this paper
• Impact of Heroin and HIV on Gut Integrity and Immune Activation

  2022cites this paper
• Clinical consequences of asymptomatic cytomegalovirus in treated human immunodeficency virus infection

  2021cites this paper
• Probing the Interface of HIV and Inflammaging

  2021cites this paper
• Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study

  2021cites this paper
• A Sex-Stratified Analysis of Monocyte Phenotypes Associated with HIV Infection in Uganda

  2021cites this paper
• PET imaging in HIV patients

  2021cites this paper
• The Adenosine Pathway and HIV-Associated Inflammation

  2021cites this paper
• The Adenosine Pathway and Human Immunodeficiency Virus-Associated Inflammation

  2021cites this paper
• Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities

  2021cites this paper
• Immunovirological Assessment of HIV-Infected Patients and Phylogenetic Analysis of the Virus in Northeast of Iran

  2021cites this paper
• Cardiovascular disease and prevention among people living with HIV in South Florida

  2021cites this paper
• Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.

  2021cites this paper
• Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling

  2021cites this paper
• Descriptive modification of inflammatory markers in HIV patients after cART initiation according to gender, smoking habit, CMV infection, BMI and serum lipids.

  2021cites this paper
• Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV

  2021cites this paper
• Lipidome association with vascular disease and inflammation in HIV+ Ugandan children

  2021cites this paper
• Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.

  2020cites this paper
• Statin Effect on Coronary Calcium Distribution, Mass and Volume Scores and Associations with Immune Activation among HIV+ Persons on Antiretroviral Therapy

  2020cites this paper
• Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV

  2020cites this paper
• Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

  2020cites this paper
• Prevention of stroke in people living with HIV.

  2020cites this paper
• A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

  2020cites this paper
• Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV

  2020cites this paper
• The association of nadir CD4-T cell count and endothelial dysfunction in a healthy HIV cohort without major cardiovascular risk factors

  2020cites this paper
• NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease

  2020cites this paper
• Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection

  2020cites this paper
• Association between statin use, atherosclerosis, and mortality in HIV-infected adults

  2020cites this paper
• Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors.

  2020cites this paper
• Subclinical Vascular Disease in Children with HIV in Uganda is Associated with Intestinal Barrier Dysfunction.

  2019cites this paper
• Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection

  2019cites this paper
• Assessing inflammation and its role in comorbidities among persons living with HIV

  2019cites this paper
• Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.

  2019cites this paper
• Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

  2019cites this paper
• Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection

  2019cites this paper
• AHA SCIENTIFIC STATEMENT Characteristics , Prevention , and Management of Cardiovascular Disease in People Living With HIV A Scientific Statement From the American Heart Association Circulation

  2019cites this paper
• Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

  2019cites this paper
• A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Hiv-Associated Chronic Inflammation.

  2019cites this paper
• No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

  2019cites this paper
• Association of Statin Use with Kidney Damage and Function Among HIV-infected Men

  2019cites this paper
• Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection

  2019cites this paper
• Brief Report: Zinc Supplementation and Inflammation in Treated HIV.

  2019cites this paper
• Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

  2019cites this paper
• The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa.

  2019cites this paper
• Novel mediators of statin effects on plaque in HIV: a proteomics approach

  2018cites this paper
• Nicotinic Acetylcholine Receptors in HIV: Possible Roles During HAND and Inflammation

  2018cites this paper
• Inefficient HIV-1 trans Infection of CD4+ T Cells by Macrophages from HIV-1 Nonprogressors Is Associated with Altered Membrane Cholesterol and DC-SIGN

  2018cites this paper
• Cellular cholesterol regulation of HIV-1 trafficking during macrophage-mediated trans infection

  2018cites this paper
• Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease.

  2018cites this paper
• Heart and Circulation

  2017cites this paper
• Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection

  2017cites this paper
• High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid

  2017cites this paper
• Effect of statin on arginine metabolites in treated HIV-infection.

  2017cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

  2017cites this paper
• Gestione del rischio cardiovascolare nel paziente HIV positivo@@@Cardiovascular risk management in HIV-infected patients

  2017cites this paper
• Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV

  2017cites this paper
• Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.

  2017cites this paper
• Therapeutic Considerations in HIV-Associated Neurocognitive Disorders

  2017cites this paper
• Aging and comorbidity among HIV-infected individuals

  2017cites this paper
• Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy

  2017cites this paper
• Cardiovascular Disease Imaging in HIV: Novel Phenotypes and New Targets for Risk Reduction.

  2017cites this paper
• Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer

  2017cites this paper
• Steven Grinspoon and Udo Hoffmann Reduction Cardiovascular Disease Imaging in HIV : Novel Phenotypes and New Targets for Risk

  2017cites this paper
• Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV

  2017cites this paper
• HIV-positive youth who are perinatally infected have impaired endothelial function

  2017cites this paper
• Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV

  2017cites this paper
• Cardiovascular disease risk among women living with HIV in North America and Europe

  2017cites this paper
• Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use.

  2017cites this paper
• Evidence-based review of statin use in patients with HIV on antiretroviral therapy

  2017cites this paper
• Monocyte and macrophage apoptosis and activation during HIV-1 infection and antiretroviral therapy

  2016cites this paper
• Cellular and molecular influences on pro-thrombotic and pro-inflammatory states in young patients with coronary artery disease

  2016cites this paper
• Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy

  2016cites this paper
• Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders

  2016cites this paper